Keywords: digibind, results, disappoint, protherics, uk-based, biopharmaceutical, company

Digibind results disappoint Protherics

Article | 28 April 2008

Print This

UK-based biopharmaceutical company Protherics did not receive the results it hoped for in the DEEP trial on Digibind (digoxin immune ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in